Of the 349 newly diagnosed adult Chinese AML patients, 35 patients (10.03%) had IDH1 mutations, including 4 IDH1 R132 mutation patients and 31 IDH1 non-R132 mutation patients. The gene discussed is IDH1; the disease is acute myeloid leukemia.